small molecule

MIDAZOLAM IN 0.8% SODIUM CHLORIDE

MIDAZOLAM

Loss of exclusivity—loss of exclusivity

CompanyExela Pharma Sciences Llc →See this company's full patent-cliff portfolio

Drug detail

Brand name	MIDAZOLAM IN 0.8% SODIUM CHLORIDE
Active ingredient	MIDAZOLAM
Strength	100MG/100ML (1MG/ML)
Dosage form	SOLUTION
Route	INTRAVENOUS
Modality	Small molecule
FDA approval	July 2022
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.